Teva Pharmaceutical Kicks Off $1B Debt Offering
Israel-based global drugmaker Teva Pharmaceutical Industries Ltd. on Thursday launched a $1 billion debt offering with maturities ranging from 2016 through 2036, in order to lower its overall interest expense....To view the full article, register now.
Already a subscriber? Click here to view full article